Immunotherapy and SBRT for Metastatic Head and Neck Carcinomas

Clinical trial NCT03283605 · COMPLETED

Trial details

NCT number: NCT03283605
Sponsor: Centre hospitalier de l'Université de Montréal (CHUM)
Status: COMPLETED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Head and Neck Squamous Cell Carcinoma Metastatic Squamous Cell Carcinoma

Start date: 2018-07-17
Primary completion: 2024-07-31
Enrollment: 33

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.